2. Academic Validation
  3. Solifenacin succinate for the treatment of overactive bladder

Solifenacin succinate for the treatment of overactive bladder

  • Expert Opin Drug Metab Toxicol. 2009 Mar;5(3):345-50. doi: 10.1517/17425250902762866.
Susan Hoffstetter 1,  Fah Che Leong
Affiliations

Affiliation

  • 1 Saint Louis University, School of Medicine, Department of Obstetrics, Gynecology and Women's Health, St. Louis, MO 63117, USA. [email protected]
PMID: 19331596 DOI: 10.1517/17425250902762866
Abstract

Solifenacin succinate, a competitive muscarinic receptor antagonist, is one of the newer options for the treatment of overactive bladder in men and women.

Objective: To review the pharmacology, efficacy and tolerability for the treatment of overactive bladder with solifenacin succinate.

Methods: A literature search was done using the keywords YM905 and solifenacin succinate.

Conclusion: Solifenacin succinate was shown to be effective for symptom control with an increase in volume voided, improvement in quality of life and a decrease in a common side effect of dry mouth compared to other medications.

Figures
Products